7,574 Shares in Astera Labs, Inc. $ALAB Bought by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management initiated a position in Astera Labs, buying 7,574 shares valued at approximately $3.66 million. Institutional investors and hedge funds collectively own 60.47% of ALAB.
• Astera Labs reported strong quarterly results, with revenue rising 104.5% year over year to $392.4 million and EPS of $0.80, beating analyst expectations. Analysts see continued potential from AI infrastructure, PCIe demand and AMD’s expanding ecosystem.
• The stock carries significant valuation and execution risks: it trades at a P/E ratio above 150, remains below its 50-day moving average, and insiders sold about $362.8 million of shares last quarter. Wall Street’s consensus rating is “Moderate Buy,” with an average price target of $325.25.

Assenagon Asset Management S.A. bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 7,574 shares of the company's stock, valued at approximately $3,658,000.

Several other hedge funds have also recently modified their holdings of ALAB. Eurizon Capital SGR S.p.A. bought a new position in Astera Labs in the 4th quarter valued at approximately $18,708,000. Swedbank AB raised its holdings in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company's stock valued at $12,999,000 after buying an additional 33,940 shares during the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in Astera Labs during the 4th quarter worth approximately $499,000. Revere Asset Management Inc bought a new stake in Astera Labs during the 4th quarter worth approximately $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp acquired a new position in shares of Astera Labs in the 4th quarter valued at about $10,299,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: AI infrastructure opportunity: Astera’s Scorpio high-radix fabric switch could become its largest revenue source, increasing average selling prices and enabling cross-selling across its connectivity portfolio. An analyst rates ALAB a Buy with a $370 price target, citing the company’s interoperability, software controls and positioning across different accelerator platforms. Astera Labs: The AI Fabric Inflection Is Arriving Faster Than Expected
• Positive Sentiment: Connectivity demand remains strong: Astera’s record growth, PCIe 6 capabilities and expanding product lineup may help it gain share against Marvell and Credo, supporting continued revenue and earnings momentum. ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?
• Positive Sentiment: Profit forecasts were sharply raised: Northland Securities lifted its FY2026 EPS estimate to $2.75 from $1.82 and its FY2027 estimate to $5.43 from $2.26. Quarterly estimates were also increased substantially, indicating expectations for faster operating growth.
• Positive Sentiment: AMD ecosystem tailwind: AMD’s Helios rack-scale AI systems are expected to ramp, potentially benefiting Astera Labs as an infrastructure and connectivity supplier alongside other ecosystem partners. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Recent coverage compares ALAB’s performance with the broader technology sector and ASE Technology, but provides no specific new catalyst or downgrade.
• Negative Sentiment: Northland maintained a “Market Perform” rating despite raising estimates. ALAB also trades at a very demanding valuation, with a price-to-earnings ratio above 200 and a share price below its 50-day average, leaving the stock sensitive to any slowdown in AI spending or execution.

Insider Activity

In related news, Director Manuel Alba sold 8,491 shares of the company's stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the transaction, the director owned 286,863 shares in the company, valued at $131,492,261.94. This represents a 2.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm's stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total value of $1,092,964.15. Following the completion of the sale, the director directly owned 53,961 shares of the company's stock, valued at $16,826,658.63. The trade was a 6.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,256,894 shares of company stock worth $362,763,135 in the last quarter. Insiders own 10.40% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Bank of America lifted their target price on Astera Labs from $240.00 to $450.00 and gave the stock a "neutral" rating in a report on Tuesday, June 23rd. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a "neutral" rating and a $153.00 price objective for the company. TD Cowen lowered their price target on shares of Astera Labs from $425.00 to $375.00 and set a "hold" rating on the stock in a report on Wednesday, August 5th. Morgan Stanley raised their target price on Astera Labs to $335.00 and gave the stock an "overweight" rating in a research report on Monday, August 3rd. Finally, Weiss Ratings raised shares of Astera Labs from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday, May 21st. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average target price of $325.25.

Astera Labs Stock Performance

ALAB stock opened at $318.80 on Thursday. The company has a market capitalization of $55.31 billion, a PE ratio of 157.82 and a beta of 3.84. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The company's 50 day moving average price is $358.62 and its two-hundred day moving average price is $238.55.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million for the quarter, compared to analysts' expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company's revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source